Related Experiment Videos
In vitro selection of Junin virus antigenic variants
1Department of Biochemistry, School of Science, University of Buenos Aires, Argentine.
Archives of Virology
|January 1, 1993
Summary
Junin virus causes Argentine hemorrhagic fever and develops variants in infected rodents. These Junin virus variants also emerged in cell cultures under antibody pressure, suggesting immune and host cell roles.
Area of Science:
- Virology
- Immunology
- Infectious Diseases
Background:
- Junin virus is the causative agent of Argentine hemorrhagic fever.
- Persistent Junin virus infections in the rodent Calomys musculinus lead to the emergence of viral antigenic variants.
- These variants are observed in both the brain and blood of infected animals.
Purpose of the Study:
- To investigate the emergence of Junin virus antigenic variants in vitro.
- To explore the role of selective pressure, specifically polyclonal antibodies, in variant emergence.
- To discuss the involvement of neutralizing antibodies and host cells in the in vivo appearance of viral variants.
Main Methods:
- Establishing experimental persistent Junin virus infections in Calomys musculinus.
- Isolating viral antigenic variants from infected animal tissues (brain and blood).
- Applying selective pressure using polyclonal antibodies in vitro to isolate variants from infected cell cultures (C. musculinus primary embryo fibroblasts).
Main Results:
- Antigenic variants of Junin virus were successfully isolated from experimentally infected C. musculinus.
- Viral variants were also isolated in vitro from long-term infected fibroblast cultures subjected to polyclonal antibody pressure.
- This demonstrates that in vitro conditions can mimic the emergence of viral variants seen in vivo.
Conclusions:
- The study confirms the emergence of Junin virus antigenic variants during persistent infection.
- In vitro experiments show that polyclonal antibodies can act as a selective pressure for variant emergence.
- The findings suggest a significant role for both neutralizing antibodies and host cells in the development of Junin virus variants within a living organism.